CASQ2 anticorps (AA 124-398)

N° du produit ABIN1885992

Cet anticorps anti-CASQ2 est un anticorps Lapin Polyclonal détectant CASQ2 dans WB et IHC. Adapté pour Humain.

Aperçu rapide pour CASQ2 anticorps (AA 124-398) (ABIN1885992)

Antigène: CASQ2 (Calsequestrin 2 (CASQ2))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp CASQ2 est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (IHC)

Détail du produit anti-CASQ2 anticorps

Épitope: AA 124-398

Purification: Purified by antigen-affinity chromatography.

Immunogène: Recombinant protein fragment contain a sequence corresponding to a region within amino acids 124 and 398 of Human CASQ2

Information d'application

Indications d'application: Suggested dilutions:
Western blotting: 1.500-1.3000
Immunohistochemistry: 1.50-1.500

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: 0.1 M Tris-buffered saline with 10 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.

Agent conservateur: Thimerosal (Merthiolate)

Précaution d'utilisation: Biohazard Informations: This product contains thimerosal which is hazardous.

Stock: 4 °C/-20 °C

Stockage commentaire: Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.

Détails sur CASQ2

Antigène: CASQ2 (Calsequestrin 2 (CASQ2))

Autre désignation: Calsequestrin-2

Sujet: The protein encoded by this gene specifies the cardiac muscle family member of the calsequestrin family.Calsequestrin is localized to the sarcoplasmic reticulum in cardiac and slow skeletal muscle cells.The protein is a calcium binding protein that stores calcium for muscle function.Mutations in this gene cause stress-induced polymorphic ventricular tachycardia, also referred to as catecholaminergic polymorphic ventricular tachycardia 2 (CPVT2), a disease characterized by bidirectional ventricular tachycardia that may lead to cardiac arrest.[provided by RefSeq]

Poids moléculaire: 46 kDa

ID gène: 845

NCBI Accession: NP_001223, NM_001232

Pathways: Negative Regulation of Transporter Activity